Research Associate I - Gene Editing & Molecular Biology

BioSpace; Frederick (MD); On-site; USD 60,000 - 85,000; Full time

Job summary

The Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc., seeks a skilled molecular biologist to join the Laboratory Animal Sciences Program (LASP) at the Frederick facility. The role focuses on designing gene editing reagents, validating them in cultured cells, and performing downstream molecular analyses to support cutting-edge cancer research.

Responsibilities include DNA input preparation for Illumina sequencing, PCR assay development, and rigorous

Qualifications

• Bachelor’s degree or four years of relevant experience; CHEA evaluation for foreign degrees.
• Minimum two years of experience in laboratory molecular biology.
• Experience maintaining and manipulating cultured cells using sterile techniques.
• Experience designing and performing PCR experiments.
• Ability to obtain and maintain a security clearance.

Responsibilities

• Design and build reagents for gene editing experiments.
• Testing gene editing reagents in cultured cells.
• Isolating nucleic acids from edited culture cells and performing downstream molecular biology assays (PCR).
• Preparing DNA input for high throughput Illumina sequencing.
• Analysis and interpretation of results from gene editing experiments.

Skills

PCR design

Molecular biology

Cell culture

Record keeping

Education

Bachelor’s degree or four years relevant experience

Tools

Illumina sequencing

DNA cloning

CRISPR/Cas9

Job description

The Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc., seeks a skilled molecular biologist to join the Laboratory Animal Sciences Program (LASP) at the Frederick facility. The role focuses on designing gene editing reagents, validating them in cultured cells, and performing downstream molecular analyses to support cutting-edge cancer research.

Responsibilities include DNA input preparation for Illumina sequencing, PCR assay development, and rigorous